ClinicalTrials.gov record
Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome
ClinicalTrials.gov ID: NCT04401748
Public ClinicalTrials.gov record NCT04401748. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
ClinicalTrials.gov public records Last synced May 10, 2026, 9:42 AM EDT
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Phase 3 Study Evaluating the Safety and Efficacy of Venetoclax in Combination With Azacitidine in Patients Newly Diagnosed With Higher-Risk Myelodysplastic Syndrome (Higher-Risk MDS)
Study identification
- NCT ID
- NCT04401748
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 531 participants
Conditions and interventions
Conditions
Interventions
- Azacitidine Drug
- Placebo Drug
- Venetoclax Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 9, 2020
- Primary completion
- Jun 30, 2027
- Completion
- Jun 30, 2027
- Last update posted
- May 5, 2026
2020 – 2027
United States locations
- U.S. sites
- 58
- U.S. states
- 28
- U.S. cities
- 53
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Duplicate_Providence Medical Foundation /ID# 222633 | Fullerton | California | 92835 | — |
| University of California, Los Angeles /ID# 221760 | Los Angeles | California | 90095 | — |
| Torrance Memorial Physician Network Cancer Care /ID# 222702 | Torrance | California | 90505-5004 | — |
| PIH Health Whittier Hospital /ID# 222647 | Whittier | California | 90602-1006 | — |
| Rocky Mountain Cancer Centers - Boulder /ID# 223723 | Boulder | Colorado | 80303 | — |
| Yale University School of Medicine /ID# 222764 | New Haven | Connecticut | 06510 | — |
| Helen F. Graham Cancer Center & Research Institute /ID# 223731 | Newark | Delaware | 19713-2055 | — |
| Florida Cancer Specialists - Fort Myers /ID# 221319 | Fort Myers | Florida | 33916 | — |
| Memorial Healthcare System /ID# 222703 | Hollywood | Florida | 33021-3513 | — |
| Florida Cancer Specialists - North /ID# 221318 | St. Petersburg | Florida | 33705-1449 | — |
| Florida Cancer Specialists - Panhandle /ID# 221315 | Tallahassee | Florida | 32308-5304 | — |
| Florida Cancer Specialists - East /ID# 221317 | West Palm Beach | Florida | 33401 | — |
| St. Luke's Mountain State Tumor Institute /ID# 220838 | Boise | Idaho | 83712-6267 | — |
| Northwestern University Feinberg School of Medicine /ID# 220843 | Chicago | Illinois | 60611-2927 | — |
| Duplicate_Rush University Medical Center /ID# 221007 | Chicago | Illinois | 60612 | — |
| Ingalls Memorial Hosp /ID# 220844 | Harvey | Illinois | 60426 | — |
| Illinois Cancer Care, PC /ID# 220840 | Peoria | Illinois | 61615 | — |
| Duplicate_Parkview Cancer Institute /ID# 223620 | Fort Wayne | Indiana | 46845-1739 | — |
| Cancer Center of Kansas /ID# 222648 | Wichita | Kansas | 67214 | — |
| Hematology/Oncology Clinic /ID# 224257 | Baton Rouge | Louisiana | 70809 | — |
| Pontchartrain Cancer Center - Covington /ID# 221005 | Covington | Louisiana | 70433-7512 | — |
| Maryland Oncology Hematology /ID# 223776 | Columbia | Maryland | 21044-3128 | — |
| Massachusetts General Hospital /ID# 225068 | Boston | Massachusetts | 02114 | — |
| Beth Israel Deaconess Medical Center /ID# 225069 | Boston | Massachusetts | 02215-5400 | — |
| Dana-Farber Cancer Institute /ID# 219162 | Boston | Massachusetts | 02215 | — |
| VA Ann Arbor Healthcare System /ID# 221365 | Ann Arbor | Michigan | 48105 | — |
| Cancer & Hematology Centers /ID# 220848 | Grand Rapids | Michigan | 49503 | — |
| Metro Minnesota Community Oncology Research Consortium (MMCORC) /ID# 221321 | Saint Louis Park | Minnesota | 55416 | — |
| MidAmerica Division, Inc. /ID# 221895 | Kansas City | Missouri | 64132 | — |
| Comprehensive Cancer Centers of Nevada - Horizon Ridge /ID# 222635 | Henderson | Nevada | 89052-2648 | — |
| Titan Health Partners LLC, d/b/a Astera Cancer Care /ID# 221003 | East Brunswick | New Jersey | 08816 | — |
| The Valley Hospital /ID# 232337 | Paramus | New Jersey | 07652 | — |
| New York Oncology Hematology - Albany Cancer Center /ID# 223778 | Albany | New York | 12206-5013 | — |
| University at Buffalo /ID# 221206 | Buffalo | New York | 14222 | — |
| Weill Cornell Medical College /ID# 222898 | New York | New York | 10065 | — |
| Stony Brook University Hospital /ID# 224450 | Stony Brook | New York | 11794-8183 | — |
| Novant Health Presbyterian Medical Center /ID# 222561 | Charlotte | North Carolina | 28204 | — |
| Novant Health Forsyth Medical Center /ID# 221004 | Winston-Salem | North Carolina | 27103 | — |
| Oncology Hematology Care, Inc. /ID# 223724 | Cincinnati | Ohio | 45236-2725 | — |
| Bend Memorial Clinic /ID# 220999 | Bend | Oregon | 97701 | — |
| Willamette Valley Cancer Institute and Research Center /ID# 223733 | Eugene | Oregon | 97401-6043 | — |
| UPMC Hillman Cancer Ctr /ID# 223201 | Pittsburgh | Pennsylvania | 15232 | — |
| Avera Cancer Institute /ID# 243461 | Sioux Falls | South Dakota | 57105 | — |
| Tennessee Oncology - Chattanooga / McCallie /ID# 221311 | Chattanooga | Tennessee | 37404-3230 | — |
| Tennessee Oncology-Nashville Centennial /ID# 220854 | Nashville | Tennessee | 37203-1632 | — |
| Texas Oncology - Austin Midtown /ID# 223729 | Austin | Texas | 78705 | — |
| Duplicate_Texas Oncology - Medical City Dallas /ID# 223725 | Dallas | Texas | 75230 | — |
| Texas Oncology- Baylor Charles A. Sammons Cancer Center /ID# 223727 | Dallas | Texas | 75246-2003 | — |
| Texas Oncology - Forth Worth /ID# 223777 | Fort Worth | Texas | 76104-2150 | — |
| MD Anderson Cancer Center at Texas Medical Center /ID# 219163 | Houston | Texas | 77030-4000 | — |
| Texas Oncology - San Antonio Medical Center - Research Drive /ID# 223728 | San Antonio | Texas | 78240 | — |
| Baylor Scott & White Medical Center- Temple /ID# 221332 | Temple | Texas | 76508-0001 | — |
| Texas Oncology - Northeast Texas /ID# 223734 | Tyler | Texas | 75702 | — |
| Utah Cancer Specialists Salt Lake Clinic /ID# 219160 | Salt Lake City | Utah | 84106 | — |
| Virginia Cancer Specialists - Gainesville /ID# 223726 | Gainesville | Virginia | 20155-3257 | — |
| Virginia Commonwealth University Medical Center Main Hospital /ID# 221590 | Richmond | Virginia | 23219 | — |
| Virginia Cancer Institute at Reynolds Crossing /ID# 221002 | Richmond | Virginia | 23230 | — |
| VA Puget Sound Health Care System /ID# 221358 | Seattle | Washington | 98108-1597 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 162 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04401748, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 5, 2026 · Synced May 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04401748 live on ClinicalTrials.gov.